Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP block and Dexmedetomidine for analgesia in live liver donors
NCT03393988Phase 4Unknown
- Sponsor
- Ain Shams University
- Start
- Dec 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine, bupivacaine hydrochloride 0.75% injection in pain, sponsored by Ain Shams University. Status: unknown.
02
Drugs
dexmedetomidinebupivacaine hydrochloride 0.75% injection
03
Conditions
pain
Beyond the preview
Go deeper on NCT03393988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03393988.